Loading company…
Chicago-based rMark Bio, Inc. offers Within3, an insights management platform for life sciences and pharmaceutical teams.
Founded in 2015, the company has completed three deals, most recently raising USD 2.77 mn from CerraCap Ventures on October 3, 2020. Within3 streamlines gathering and analyzing insights, with a stated aim of cutting reporting time from months to days and reducing analysis workload by up to 90%. Revenue comes from subscription contracts.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in